Low-frequency electroacupuncture improves disordered hepatic energy metabolism in insulin-resistant Zucker diabetic fatty rats via the AMPK/mTORC1/p70S6K signaling pathway

Abstract

Background and aim:

Disordered hepatic energy metabolism is found in obese rats with insulin resistance (IR). There are insufficient experimental studies of electroacupuncture (EA) for IR and type 2 diabetes mellitus (T2DM). The aim of this study was to probe the effect of EA on disordered hepatic energy metabolism and the adenosine monophosphate (AMP)-activated protein kinase (AMPK)/mammalian target of rapamycin complex 1 (mTORC1)/ribosomal protein S6 kinase, 70-kDa (p70S6K) signaling pathway.

Methods:

Zucker Diabetic Fatty (ZDF) rats were randomly divided into three groups: EA group receiving EA treatment; Pi group receiving pioglitazone gavage; and ZF group remaining untreated (n = 8 per group). Inbred non-insulin-resistant Zucker lean rats formed an (untreated) healthy control group (ZL, n = 8). Fasting plasma glucose (FPG), fasting insulin (FINS), C-peptide, C-reactive protein (CRP) and homeostatic model assessment of insulin resistance (HOMA-IR) indices were measured. Hematoxylin–eosin (H&E) staining was used to investigate the liver morphologically. The mitochondrial structure of hepatocytes was observed by transmission electron microscopy (TEM). Western blotting was adopted to determine protein expression of insulin receptor substrate 1 (IRS-1), mTOR, mTORC1, AMPK, tuberous sclerosis 2 (TSC2) and p70S6K, and their phosphorylation. RT-PCR was used to quantify IRS-1, mTOR, mTORC1, AMPK and p70S6K mRNA levels.

Results:

Compared with the ZF group, FPG, FINS, C-peptide, CRP and HOMA-IR levels were significantly reduced in the EA group (p < 0.05, p < 0.01). Evaluation of histopathology showed improvement in liver appearances following EA. Phosphorylation levels of AMPK, mTOR and TSC2 decreased, and IRS-1 and p70S6K increased, in hepatocytes of the ZF group, while these negative effects appeared to be alleviated by EA.

Conclusions:

EA can effectively ameliorate IR and regulate energy metabolism in the ZDF rat model. AMPK/mTORC1/p70S6K and related molecules may represent a potential mechanism of action underlying these effects.

Keywords

acupuncture diabetes electroacupuncture

Get full access to this article

View all access options for this article.

References

Tuomilehto

The emerging global epidemic of type 1 diabetes. Curr Diab Rep 2013; 13(6): 795–804.

Zheng

Ley

FB.

Global aetiology and epidemiology of type 2 diabetes mellitus and its complication. Nat Rev Endocrinol 2018; 14(2): 88–98.

Saeedi

Petersohn

Salpea

, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the international diabetes federation diabetes Atlas, 9th edition. Diabetes Res Clin Pract 2019; 157: 10784.

Mazibuko-Mbeje

Dludla

Johnson

, et al. Aspalathin, a natural product with the potential to reverse hepatic insulin resistance by improving energy metabolism and mitochondrial respiration. PLoS ONE 2019; 14(5): e0216172.

Roberts

Hevener

Barnard

RJ.

Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training. Compr Physiol 2013; 3(1): 1–58.

Rui

Energy metabolism in the liver. Compr Physiol 2014; 4(1): 177–197.

Moore

Coate

Winnick

, et al. Regulation of hepatic glucose uptake and storage in vivo. Adv Nutr 2012; 3(3): 286–294.

Nakagawa

Satoh

Yabe

, et al. Hepatic CREB3L3 controls whole-body energy homeostasis and improves obesity and diabetes. Endocrinology 2014; 155(12): 4706–4719.

Watt

Miotto

De Nardo

, et al. The Liver as an Endocrine Organ—Linking NAFLD and Insulin Resistance. Endocr Rev 2019; 40(5): 1367–1393.

10.

Kraegen

Clark

Jenkins

, et al. Development of muscle insulin resistance after liver insulin resistance in high-fat-fed rats. Diabetes 1991; 40(11): 1397–1403.

11.

Turner

Kowalski

Leslie

, et al. Distinct patterns of tissue-specific lipid accumulation during the induction of insulin resistance in mice by high-fat feeding. Diabetologia 2013; 56(7): 1638–1648.

12.

Inoki

Kim

Guan

KL.

AMPK and mTOR in cellular energy homeostasis and drug targets. Annu Rev Pharmacol Toxicol 2012; 52: 381–400.

13.

Kimball

Siegfried

Jefferson

LS.

Glucagon represses signaling through the mammalian target of rapamycin in rat liver by activating AMP-activated protein kinase. J Biol Chem 2004; 279(52): 54103–54109.

14.

Le Bacquer

Petroulakis

Paglialunga

, et al. Elevated sensitivity to diet-induced obesity and insulin resistance in mice lacking 4E-BP1 and 4E-BP2. J Clin Invest 2007; 117(2): 387–396.

15.

Frigerio

Watanabe

, et al. Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature 2004; 431(7005): 200–205.

16.

Saha

Avilucea

, et al. Pioglitazone treatment activates AMP-activated protein kinase in rat liver and adipose tissue in vivo. Biochem Biophys Res Commun 2004; 314(2): 580–585.

17.

Shah

Mudaliar

Pioglitazone: side effect and safety profile. Expert Opin Drug Saf 2010; 9(2): 347–354.

18.

Shadid

Jensen

MD.

Angioneurotic edema as a side effect of pioglitazone. Diabetes Care 2002; 25(2): 405.

19.

Liang

Koya

Acupuncture: is it effective for treatment of insulin resistance. Diabetes Obes Metab 2010; 12(7): 555–569.

20.

Litscher

The application of bioengineering of acupuncture to the treatment of diabetes, insulin resistance and obesity. Diabetes Obes Metab 2010; 12(7): 553–554.

21.

Cabioglu

Gündogan

Ergene

The efficacy of electroacupuncture therapy for weight loss changes plasma lipoprotein A, apolipoprotein A and apolipoprotein B levels in obese women. Am J Chin Med 2008; 36(6): 1029–1039.

22.

Cabioğlu

Ergene

Changes in levels of serum insulin, C-Peptide and glucose after electroacupuncture and diet therapy in obese women. Am J Chin Med 2006; 34(3): 367–376.

23.

Lin

Tzeng

Lee

, et al. Acute effect of electroacupuncture at the Zusanli acupoints on decreasing insulin resistance as shown by lowering plasma free fatty acid levels in steroid-background male rats. BMC Complement Altern Med 2009; 9: 26.

24.

Cao

Tian

, et al. PI3K-GLUT4 signal pathway associated with effects of EX-B3 electroacupuncture on hyperglycemia and insulin resistance of T2DM rats. Evid Based Complement Alternat Med 2016; 2016: 7914387.

25.

Tominaga

Ishizaki

Naruse

, et al. Repeated application of low-frequency electroacupuncture improves high-fructose diet-induced insulin resistance in rats. Acupunct Med 2011; 29(4): 276–283.

26.

Srinivasan

Ramarao

Animal models in type 2 diabetes research: an overview. Indian J Med Res 2007; 125(3): 451–472.

27.

Haeusler

Accili

The double life of IRS. Cell Metab 2008; 8(1): 7–9.

28.

Kahn

Flier

JS.

Obesity and insulin resistance. J Clin Invest 2000; 106(4): 473–481.

29.

Savage

Petersen

Shulman

GI.

Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol Rev 2007; 87(2): 507–520.

30.

Unger

RH.

Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome. Endocrinology 2003; 144(12): 5159–5165.

31.

Meex

RCR

Watt

. Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance. Nat Rev Endocrinol 2017; 13(9): 509–520.

32.

Stefan

Fritsche

Schick

, et al. Phenotypes of prediabetes and stratification of cardiometabolic risk. Lancet Diabetes Endocrinol 2016; 4(9): 789–798.

33.

Inoki

, et al. Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev 2003; 17(15): 1829–1834.